Open Access

Nanosecond electric pulses are equally effective in electrochemotherapy with cisplatin as microsecond pulses

Angelika Vizintin
Angelika Vizintin
, 
Stefan Markovic
Stefan Markovic
, 
Janez Scancar
Janez Scancar
, 
Jerneja Kladnik
Jerneja Kladnik
, 
Iztok Turel
Iztok Turel
 and 
Damijan Miklavcic
Damijan Miklavcic
   | Nov 30, 2023
Radiology and Oncology's Cover Image
About this article
Previous Article
Next Article
Cite
Article Category: Erratum
Published Online: Nov 30, 2023
Page range: 550 - 550
Received: Jun 07, 2022
Accepted: Jun 19, 2022
DOI: https://doi.org/10.2478/raon-2023-0049
© 2023 Angelika Vizintin et al., published by Sciendo
This work is licensed under the Creative Commons Attribution 4.0 International License.

In Figure 3A, three horizontal bars representing the standard deviation were incorrectly drawn. The corrected figure is shown below.

FIGURE 3.

Cell survival as a function of the number of cisplatin molecules per cell for (A) CHO cells and (B) B16F1 cells in nonelectroporated (non-EP) cells (black circles) and cells electroporated with 25 × 400 ns pulses at 3.9 kV/cm, 10 Hz repetition rate (dark blue squares), 1 × 200 ns pulse at 12.6 kV/cm (light blue diamonds) or 8 × 100 μs pulses at 1.1 (CHO) or 0.9 (B16F1) kV/cm, 1 Hz pulse repetition rate (orange triangles). Bars represent standard deviation. Survival data were combined from the previous8 (for non-electroporated CHO cells and CHO cells electroporated with 25 × 400 ns and 8 × 100 μs pulses) and the present study (for B16F1 cells, additional non-electroporated CHO cells and CHO cells electroporated with 1 × 200 ns pulse).

eISSN:
1581-3207
Language:
English
Publication timeframe:
4 times per year
Journal Subjects:
Medicine, Clinical Medicine, Internal Medicine, Haematology, Oncology, Radiology
Journal RSS Feed